Top Ranked Value Stocks to Buy for June 23rd

VALE LEN BZH

Here are four stocks with buy rank and strong value characteristics for investors to consider today, June 23rd:

Vale S.A. (VALE - Free Report) : This mining company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 23.8% over the last 60 days.

 

Vale has a price-to-earnings ratio (P/E) of 4.56, compared with 6.60 for the industry. The company possesses a Value Score of B.

 

Atlas Air Worldwide Holdings, Inc. : This company that through its subsidiaries, provides outsourced aircraft and aviation operating services has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising nearly 46% over the last 60 days.

 

Atlas Air Worldwide has a price-to-earnings ratio (P/E) of 5.62, compared with 17.90 for the industry. The company possesses a Value Score of A.

 

Beazer Homes USA, Inc. (BZH - Free Report) : This company that designs, builds and sells single family homes has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 36.4% over the last 60 days.

 

Beazer Homes has a price-to-earnings ratio (P/E) of 7.01, compared with 8.80 for the industry. The company possesses a Value Score of A.

 

Lennar Corporation (LEN - Free Report) : This company that together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 19.3% over the last 60 days.

 

Lennar Corp. has a price-to-earnings ratio (P/E) of 7.24, compared with 8.80 for the industry. The company possesses a Value Score of B.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>